Article info

Download PDFPDF
Review
Drug repurposing in neurological diseases: an integrated approach to reduce trial and error

Authors

  • Alexander E Clout Department of Pharmaceutics, UCL School of Pharmacy, London, UK PubMed articlesGoogle scholar articles
  • Oscar Della Pasqua Clinical Pharmacology and Therapeutics Group, UCL School of Pharmacy, London, UK Clinical Pharmacology Modelling and Simulation, GlaxoSmithKline, Uxbridge, UK PubMed articlesGoogle scholar articles
  • Michael G Hanna MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  • Mine Orlu Department of Pharmaceutics, UCL School of Pharmacy, London, UK PubMed articlesGoogle scholar articles
  • Robert D S Pitceathly MRC Centre for Neuromuscular Diseases, UCL Queen Square Institute of Neurology and National Hospital for Neurology and Neurosurgery, London, UK Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Robert D S Pitceathly; r.pitceathly{at}ucl.ac.uk; Dr Mine Orlu; m.orlu{at}ucl.ac.uk
View Full Text

Citation

Clout AE, Della Pasqua O, Hanna MG, et al
Drug repurposing in neurological diseases: an integrated approach to reduce trial and error

Publication history

  • Received March 26, 2019
  • Revised May 2, 2019
  • Accepted May 3, 2019
  • First published June 6, 2019.
Online issue publication 
October 10, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.